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Abstract
Background—We investigated whether maternal exposure to cigarette smoke was associated 
with omphalocoele and whether periconceptional folic acid modified the association.
Methods—We analysed data from the National Birth Defects Prevention Study on omphalocoele 
case (n = 301) and control (n = 8135) mothers for infants born from 1997 through 2007. Mothers 
who reported active smoking or exposure to second-hand smoke during the periconceptional 
period (1 month before conception to 3 months after) were considered exposed. Those who 
reported use of folic acid supplements during the same period were considered supplement users. 
Odds ratios and 95% confidence intervals were estimated using multivariable logistic regression 
adjusted for alcohol use, preconception body mass index, and race/ethnicity.
Results—One hundred fifteen (38.2%) case and 2592 (31.9%) control mothers reported exposure 
to cigarette smoke during the periconceptional period. Adjusted odds ratios [95% confidence 
intervals] were 1.19 [0.94, 1.53] for any smoke exposure, 0.87 [0.54, 1.40] for active smoking, 
1.38 [1.00, 1.90] for second-hand smoke exposure, and 1.16 [0.80, 1.67] for both exposures 
combined. No dose-response relationship was observed. Folic acid-containing supplements did not 
reduce the risk for omphalocoele among women with active or second-hand smoke exposure.
Conclusions—Self-reported active maternal smoking, with or without exposure to second-hand 
smoke, during the periconceptional period was not associated with omphalocoele. In contrast, 
there was a possible association with periconceptional exposure to second-hand smoke.
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Omphalocoele is a midline abdominal wall defect consisting of a membrane-covered 
herniation of abdominal organs through a widened umbilical ring.1 Omphalocoele may 
develop in the embryo before1 or after2 normal physiologic herniation (6 to 10 weeks post-
conception) making it more challenging to assess its relation to environmental exposures. 
Though the aetiology of non-syndromic omphalocoele is not known, associations have been 
reported with young as well as advanced maternal age,4 alcohol consumption,5 US born 
Hispanic mothers,4 obesity,6 clomiphene citrate,7 hot tub use,8 asthma medication,9 and 
heavy smoking.5 Maternal cigarette smoking during pregnancy is known to cause adverse 
pregnancy outcomes10-12 including birth defects.13-17 We used data from the National Birth 
Defects Prevention Study (NBDPS) to investigate whether non-syndromic omphalocoele 
was associated with self-reported active maternal cigarette smoking and/ or exposure to 
second-hand smoke. We also examined whether such association was modified by 
periconceptional folic acid.
Methods
The NBDPS is the largest population-based case-control study of birth defects in the US. 
Nine sites (Arkansas, California, Iowa, Massachusetts, New Jersey, New York, North 
Carolina, Texas, and Utah) and the Centers for Disease Control and Prevention (CDC) 
followed a common protocol for enrolment, classification, and maternal interview.18 All 
pregnancy outcomes (liveborn, stillborn ≥20 weeks, or termination at any gestation) were 
eligible; however, not all sites were able to ascertain stillbirths and terminations.19 One 
geneticist (RSO) reviewed all case records of omphalocoele to confirm eligibility and 
classify cases as isolated (without another major birth defect) or multiple (with one or more 
additional major birth defects, such as cleft lip). Unaffected live births (controls) were 
randomly selected from birth certificates or hospital logs in the same catchment area.19 
Trained interviewers administered a telephone interview to mothers 6 weeks to 24 months 
after the estimated date of delivery (EDD) of their pregnancy.19 All sites maintained 
institutional review board approvals for the NBDPS.
Exposure assessment
Case and control mothers were queried about their smoking and exposure to second-hand 
(home, work, or school) smoke during the 3 months before conception and throughout the 
pregnancy. Those reporting having smoked were queried about the average number of 
cigarettes smoked per day. We created four groups (any exposure; active smoking only; 
exposure to second-hand smoke only; and active smoking with exposure to second-hand 
smoke) based on the exposure from 1 month before conception to 3 months after.
Inclusion criteria
Eligible case (n = 376) and control (n = 8494) infants were delivered on or after 1 October 
1997 and had an EDD prior to 1 January 2008. We excluded 54 cases associated with OEIS 
complex (Omphalocoele, bladder Exstrophy, Imperforate anus, and Spina bifida), cloacal 
exstrophy, limb–body wall complex, conjoined twins, Pentalogy of Cantrell, prune belly or 
urethral obstruction sequence, or Beckwith–Wiedemann syndrome. We also excluded 
mothers with or missing information on pre-gestational diabetes (16 cases; 245 controls) or 
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who did not complete all interview sections (i.e. break-off) (5 cases; 114 controls). After 
exclusions, 301 omphalocoele cases (181 isolated; 120 multiple), and 8135 controls were 
available for analysis.
Statistical analysis
We used unconditional logistic regression to calculate adjusted (aOR) odds ratios with 95% 
confidence intervals [95% CI]. The final logistic regression models controlled for maternal 
alcohol use (yes, no), preconception body mass index (BMI, kg/m2: <18.5, 18.5–24.9, ≥25), 
and race/etimicity (non-Hispanic White, non-Hispanic Black, Hispanic, other). We used the 
Mantel–Haenszel chi-square test to evaluate the dose relationship based on average number 
of cigarettes smoked per day. We used the relative excess risk due to interaction20 to 
evaluate whether periconceptional folic acid (with or without other prenatal or multivitamins 
or minerals) modified the association with cigarette smoke exposure.
Results
Compared to control mothers, case mothers were more likely to report a higher 
preconception BMI, periconceptional alcohol use, be interviewed more than 12 months after 
delivery, and be exposed to second-hand smoke (Table 1).
Among all cases, no statistically significant increased risks were observed for active 
smoking only or with exposure to second-hand smoke (Table 2). However, second-hand 
smoke produced a significant positive association with multiple cases.
No dose–response relationships were observed (Mantel–Haenszel chi-square test P = 0.67) 
in any of the groups (data for all omphalocoele cases based on the average number of 
cigarettes smoked per day: <15 aOR= 1.02 [95% Cl 0.72, 1.45]; 15–24 aOR = 0.82 [95% CI 
0.43, 1.53]; >24 aOR = 2.05 [95% CI 0.87, 4.82]). Folic acid supplementation did not 
modify the association between active smoking with or without exposure to second-hand 
smoke or for second-hand smoke exposure alone (data not shown).
Discussion
Active smoking during the periconceptional period was not associated with omphalocoele; 
second-hand smoke exposure only was weakly associated with omphalocoele. There was not 
a dose–response pattern among women who reported active smoking. Our results among the 
heaviest smokers (>24 cigarettes per day) (aOR 2.05 [95% CI 0.87, 4.82]) differed from 
those reported by Bird et al5 (a OR= 4.26 [95% CI 1.58, 11.52]) using an earlier NBDPS 
data set with similar dose categories. Our lower observed association may reflect the change 
in the proportion of non-smokers among control (81% to 68%) and case (75% to 80%) 
mothers during the two time periods.
Periconceptional folic acid-containing supplement use did not statistically reduce the risk for 
smoke-associated omphalocoele. In this study, maternal self-report of periconceptional use 
of folic acid included folic acid alone or folic acid contained in a multivita min (either 
prenatal vitamins or multivitamins). Reported use was very similar in case and control 
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mothers (cases 86.7%, controls 86.2%). Because of diminishing sample sizes, it was not 
possible to analyse separately multivitamin use with and without folic acid supplementation.
The biologic mechanisms linking cigarette smoking to alteration in early fetal development 
are likely complex. Mainstream cigarette smoke (exhaled smoke) creates a complex aerosol 
containing thousands of chemicals,21 whose impact, individually or synergistically, on the 
developing fetus is largely unknown. Cigarette smoking during pregnancy exposes both 
mother and the developing fetus to carbon monoxide, nicotine, and cadmium,22 as well as 
several thousand additional chemicals.23 Tobacco combustion also generates high levels of 
carbon monoxide24 contributing to reduced oxygen levels in the mother and fetus. These 
exposures also decrease both serum and red blood cell folate levels.25 Maternal cigarette 
smoking during pregnancy has been associated with several types of birth defects17,26,27 and 
mothers are strongly encouraged to discontinue smoking before becoming pregnant.
Interestingly, we observed an increased risk for omphalocoele among mothers with second-
hand exposure only. Second-hand smoke is becoming an increasing source of concern for 
several reasons. Second-hand smoke is a mixture of both mainstream and side-stream 
smoke. Side-stream smoke has been found to contain nicotine as well as toxic chemicals and 
several particulates that, because they are smaller than in mainstream smoke, are capable of 
entering the body more readily. Compared to active smoking, second-hand exposure 
introduces higher concentrations of some toxic constituents due to incomplete combustion of 
tobacco products.28 Immediate side-stream smoke is estimated to be four times more toxic 
than mainstream smoke.29 Maternal exposure to second-hand smoke during pregnancy is 
less studied, but evidence is accumulating suggesting that this exposure may increase the 
risk for several birth defects.30-32
Our findings were observed in a large and well-characterised group of non-syndromic 
omphalocoele cases identified from 10 population-based, US surveillance systems. Self-
reported smoking prior to and during pregnancy was ascertained systematically from both 
case and control mothers using trained interviewers and a structured telephone interview. 
Questions were specific to assess whether their monthly exposure prior to and during 
pregnancy was for maternal smoking and/ or exposure to second-hand smoke in the home, 
work, or school.
Use of maternal self-reports of pregnancy exposures, especially for behaviours that may not 
be socially acceptable, may limit interpretation of study findings. We relied on maternal 
self-reports for cigarette smoking anytime during the 3 months before pregnancy throughout 
the pregnancy. Mothers may not have reported their smoking or stated they discontinued 
smoking before pregnancy, when in fact they were still smoking. However, a recent study 
compared maternal self-reports for cigarette smoking from three data sources for Utah case 
and control mothers in the NBDPS; interview reports had the highest prevalence of maternal 
cigarette smoking during the periconceptional period compared to the prenatal medical 
records or the birth certificate.33 Another limitation is the embryologic timing of 
omphalocoele relative to any environmental exposure. An omphalocoele may occur either 
before six weeks or after 10 weeks post-conception. This lack of precision in the timing of 
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omphalocoele requires a broader exposure window, which may lead to some exposure 
misclassification.
In summary, we found that maternal periconceptional exposure to second-hand smoke may 
be a greater concern than exposure only to active smoking. Because of the limited power of 
these stratified analyses and novelty of the findings, replication is needed. Substantiating the 
risks associated with second-hand smoke is of crucial importance as it constitutes an 
important primary prevention message to disseminate among providers and the general 
public.
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Table 1
Crude odds ratios (cOR) for maternal characteristics and exposures among case and control mothers, National 
Birth Defects Prevention Study, 1997–2007
Cases (n = 301) Controls (n = 8135)
Maternal characteristics N % N % cOR [95%CI]
Age (years)
    <20 30 (10.0) 848 (10.4) 1.09 [0.71, 1.68)
    20–24 76 (25.3) 1876 (23.1) 1.25 [0.90, 1.73]
    25–29 73 (24.3) 2246 (27.6) 1.00 [Reference]
    ≥30 122 (40.5) 3165 (38.9) 1.19 [0.88, 1.59]
Race/ethnicity
    White, non-Hispanic 172 (57.1) 4841 (59.5) 1.00 [Reference]
    Black, non-Hispanic 46 (15.3) 910 (11.2) 1,42 [1.02, 1.98]
    Hispanic 60 (19.9) 1862 (22.9) 0.91 [0.67, 1.22]
    Other 23 (7.6) 519 (6.4) 1.25 [0.80, 1.95]
    Missing 0 3 (0.1) –
Education (years)
    <12 43 (14.3) 1383 (17.0) 1.00 [Reference]
    ≥12 258 (85.7) 6722 (82.6) 1.23 [0.89, 1.71]
    Missing 0 30 (0.4) –
Preconception BMIa
    <18.5 17 (5.7) 433 (5.3) 1.30 [0.78, 2.17]
    18.5–24.9 131 (43.5) 4325 (53.2) 1.00 [Reference]
    ≥25.0 142 (47.2) 3044 (37.4) 1.54 [1.21, 1.96]
    Missing 11 (3.7) 333 (4.1) –
Previous pregnancy
    0 103 (34.2) 2434 (29.9) 1.00 [Reference]
    >1 198 (65.8) 5700 (70.1) 0.82 [0.64, 1.05]
    Missing 0 1 (0.01) –
Fever
    No 296 (98.3) 8000 (98.3) 1.00 [Reference]
    Yes 4 (1.3) 94 (1.2) 1.15 [0.42, 3.15]
    Missing 1 (0.3) 41 (0.5) –
Substance abuse
    No 237 (78.7) 6240 (76.7) 1.00 [Reference]
    Yes 14 (4.7) 331 (4.1) 1.11 [0.64, 1.93]
    Missing 50 (16.6) 1564 (19.2) –
Alcohol Use
    No 161 (53.5) 5095 (62.6) 1.00 [Reference]
    Yes 140 (46.5) 3004 (36.9) 1.48 [1.17, 1.86]
    Missing 0 36 (0.4) –
Folic acid supplements
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Cases (n = 301) Controls (n = 8135)
Maternal characteristics N % N % cOR [95%CI]
    None 39 (13.0) 1016 (12.5) 1.00 [Reference]
    Periconceptionb 261 (86.7) 7013 (86.2) 0.97 [0.69, 1.37]
    Missing 1 (0.3) 106 (1.3) –
Gestational diabetes
    No 284 (94.4) 7746 (95.2) 1.00 [Reference]
    Yes 16 (5.3) 341 (4.2) 1.28 [0.77, 2.14]
    Missing 1 (0.3) 48 (0.6) –
Paternal age (years)
    <20 10 (3.3) 378 (4.7) 0.69 [0.35, 1.33]
    20–24 50 (16.6) 1401 (17.2) 0.92 [0.64, 1.32]
    25–29 80 (26.6) 2070 (25.5) 1.00 [Reference]
    ≥30 149 (49.5) 3971 (48.8) 0.97 [0.74, 1.28]
    Missing 12 (4.0) 315 (3.9). –
Time to interview (months)
    <12 196 (65.1) 6054 (74.4) 1.00 [Reference]
    ≥12 104 (34.6) 2054 (25.3) 1.56 [1.23, 1.99]
    Missing 1 (0.3) 27 (0.3) –
Centre
    Arkansas 38 (12.6) 1039 (12.8) 1.00 [Reference]
    California 45 (15.0) 985 (12.1) 1.25 [0.80, 1.94]
    Georgia 42 (14.0) 853 (10.5) 1.35 [0.86, 2.11]
    Iowa 25 (8.3) 900 (11.1) 0.76 [0.46, 1.27]
    Massachusetts 36 (12.0) 1003 (12.3) 0.98 [0.62, 1.56]
    New Jersey 27 (9.0) 568 (7.0) 1.30 [0.79, 2.15]
    New York 20 (6.6) 704 (8.7) 0.78 [0.45, 1.35]
    North Carolina 10 (3.3) 553 (6.8) 0.50 [0.25, 1.00]
    Texas 37 (12.3) 935 (11.5) 1.08 [0.68, 1.72]
    Utah 21 (7.0) 595 (7.3) 0.97 [0.56, 1.66]
Cigarette smoke exposure
    None 186 (61.8) 5528 (68.0) 1.00 [Reference]
    Maternal only 21 (7.0) 609 (7.5) 1.03 [0.65, 1.62]
    Second-hand smoke only 56 (18.6) 1103 (13.6) 1,51 [1.11, 2.05]
    Maternal and second-hand 38 (12.6) 880 (10.8) 1.28 [0.90, 1.83]
    Missing 0 15 (0.2) –
a
BMI = body mass index in kg/m2.
b
Includes women reporting multivitamins or prenatal vitamins with folic acid or folic acid alone.
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Table 2
Frequency and adjusted odds ratios (aOR) and 95% confidence intervals [95%CI] for maternal smoking 





Cases n = 
301 (%)
All Isolated Multiple
aOR [95% CI] (n = 181) aOR [95% CI] (n = 120) aOR [95% CI]
None 5528 186 1.00 [Reference] 120 1.00 [Reference] 66 1.00 [Reference]
Any 2592 (31.9) 115 (38.2) 1.19 [0.94, 1.53] 61 0.99 [0.72, 1.36] 54 1.58 [1.08, 2.30]
Maternal only 609 (23.5) 21 (18.3) 0.87 [0.54, 1.40] 11 0,73 [0.39, 1.37] 10 1.15 [0.56, 2.36
Second-hand 1103 (42.6) 56 (48.7) 1.38 [1.00, 1.90] 30 1.22 [0.80, 1.85] 26 1.65 [1.02, 2.66]
Maternal with second-hand 880 (34.0) 38 (33.0) 1.16 [0.80, 1.67] 20 0.89 [0.55, 1.46] 18 1.70 [0.98, 2.95]
Odds ratios adjusted for race/ethnicity, preconception BMI, and alcohol use.
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